Elevance Health has filed a lawsuit against the U.S. government in the Southern District of Georgia. The insurer alleges that federal efforts to recalculate its Medicare Advantage quality ratings didn’t align with a recent court ruling, costing the health insurer $115 million.
This legal battle represents a new tier of drama in the Medicare Advantage program, which is the alternative to traditional Medicare that is run by private insurers. The “Star Rating” system is supposed to measure the quality of a health plan’s care and customer service. Plans that meet certain quality thresholds get extra taxpayer-funded bonuses and rebates.
In Plain English: The Clinical Takeaway
How Star Ratings Dictate Patient Access and Clinical Outcomes
These ratings are supposed to measure the quality of a health plan’s care and customer service.
When a plan meets certain quality thresholds, it qualifies for taxpayer-funded bonuses and rebates. If CMS recalculates these ratings, as alleged in the Elevance suit, the insurer loses $115 million.
The Financial Stakes of Quality Reporting
The $115 million at the center of this dispute represents the amount the health insurer alleges it has been cost by federal efforts to recalculate its Medicare Advantage quality ratings. The lawsuit claims the government failed to align its recalculations with a specific court ruling.
| Rating Tier | Impact on Insurer | Potential Patient Impact |
|---|---|---|
| High Quality | Bonus Payments | Expanded supplemental benefits. |
Funding Transparency and Regulatory Bias
This lawsuit highlights a new tier of drama in the Medicare Advantage program, which is the alternative to traditional Medicare that is run by private insurers.
Contraindications & When to Consult a Doctor
The Future of Medicare Advantage Oversight
The Elevance lawsuit signals a new tier of drama in the Medicare Advantage program.
References
- U.S. District Court for the Southern District of Georgia – Case Filings
